In 2023, the Chinese pharmaceutical firm Fosun Pharmaceutical generated around 41 billion yuan of revenue, representing a drop of 5.8 percent from the previous year. Anti-tumor and immune modulation medications, such as trastuzumab and adalimumab, contributed more than 7.6 billion yuan of Fosun's revenue in 2023.
Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Fosun Pharmaceutical (Group). (March 26, 2024). Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area (in billion yuan) [Graph]. In Statista. Retrieved November 24, 2024, from https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). "Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area (in billion yuan)." Chart. March 26, 2024. Statista. Accessed November 24, 2024. https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). (2024). Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area (in billion yuan). Statista. Statista Inc.. Accessed: November 24, 2024. https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). "Revenue Generated by Major Products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by Therapeutic Area (in Billion Yuan)." Statista, Statista Inc., 26 Mar 2024, https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group), Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area (in billion yuan) Statista, https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/ (last visited November 24, 2024)
Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023, by therapeutic area (in billion yuan) [Graph], Shanghai Fosun Pharmaceutical (Group), March 26, 2024. [Online]. Available: https://www.statista.com/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
